Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current assets
Cash	$ 11,224,197	$ 16,808,539
Prepaid research and development	722,121	66,217
Other current assets	296,038	244,021
Total current assets	12,242,356	17,118,777
Deposits	127,534	127,534
Property and equipment, net	19,400	16,377
Right of use asset	400,918	638,786
Total assets	12,790,208	17,901,474
Current liabilities
Accounts payable	953,470	953,349
Accrued expenses	1,960,065	850,557
Lease liability, current portion	336,162	332,817
Short-term milestone payable due to Patagonia Pharmaceuticals LLC	1,750,000
Redeemable Series A preferred stock under redemption (Notes 5 and 9)		2,055,348
Total current liabilities	4,999,697	4,192,071
Note payable		37,772
Lease liability	83,520	331,152
Other liabilities	73,683	73,683
Total liabilities	5,156,900	4,634,678
Commitments and contingencies (Note 7)
Stockholders' equity
Common stock, par value $0.001; 450,000,000 shares authorized; 133,542,821 shares issued and outstanding as of September 30, 2022, and 63,619,140 shares issued and outstanding as of December 31, 2021	133,543	63,619
Additional paid-in capital	52,140,972	42,087,719
Accumulated deficit	(44,641,207)	(28,884,542)
Total stockholders' equity	7,633,308	13,266,796
Total liabilities and stockholders' equity	$ 12,790,208	$ 17,901,474